SEOUL (Reuters) - South Korea expects clinical trials of Celltrion Inc's experimental COVID-19 treatment to begin in Europe next month and aims to secure sizable supplies of the drug by the first half of next year, a senior health official said on Tuesday.
Drugmakers worldwide are rushing to develop treatments for the flu-like illness caused by the new coronavirus that has killed more than 374,000 globally since it first emerged late last year in China.
Already a subscriber? Log in.
Subscribe to win RM50 Touch 'n Go e-Voucher! More Info
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!